BIO BLAST PHARMA LTD's ticker is ORPN and the CUSIP is M20156101. A total of 15 filers reported holding BIO BLAST PHARMA LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $81,000 | -95.4% | 50,833 | -92.9% | 0.01% | -80.0% |
| Q1 2016 | $1,777,000 | -45.6% | 713,625 | -15.4% | 0.03% | -38.8% |
| Q4 2015 | $3,266,000 | -23.8% | 844,000 | 0.0% | 0.05% | -16.9% |
| Q3 2015 | $4,288,000 | -26.3% | 844,000 | 0.0% | 0.06% | -28.0% |
| Q2 2015 | $5,815,000 | +14.8% | 844,000 | -0.0% | 0.08% | +9.3% |
| Q1 2015 | $5,065,000 | -6.1% | 844,160 | 0.0% | 0.08% | -1.3% |
| Q4 2014 | $5,395,000 | +18.4% | 844,160 | +34.6% | 0.08% | +13.4% |
| Q3 2014 | $4,558,000 | – | 627,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 206,054 | $214,000 | 0.38% |
| Anson Funds Management LP | 270,793 | $282,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 660,157 | $687,000 | 0.04% |
| OPPENHEIMER & CO INC | 24,700 | $26,000 | 0.00% |
| UBS Group AG | 4,066 | $4,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,255 | $1,000 | 0.00% |
| Virtu KCG Holdings LLC | 15,032 | $16,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,000 | $1,000 | 0.00% |
| BlackRock Fund Advisors | 16,786 | $17,000 | 0.00% |
| MORGAN STANLEY | 1,026 | $2,000 | 0.00% |